Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
K. Ranga R. Krishnan, MD: Informant-Rated Cognitive Symptoms in Normal Aging, Mild Cognitive Impairment, and Dementia
1
x
$
30.00
Generalized Anxiety Disorder: Diagnosis, Neurobiology, and Treatment
1
x
$
30.00
Psychopharmacology Bulletin VOL 49 No. 2, 2019 - Full Issue Stacked PDF
1
x
$
90.00
Anismus-A Very Unusual Extrapyramidal Side Effect of Paliperidone Palmitate in an Adolescent with Schizo-Affective Disorder
1
x
$
30.00
Vilazodone - Safety and Tolerability Profile PB VOL 44 No. 3
1
x
$
30.00
M. Ojinga Harrison, MD: Antipsychotic Medications and Sudden Cardiac Death
1
x
$
30.00
View Cart
Checkout
Home
double-blind
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Treatment of Children with Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Multicenter, Double-Blind, Crossover Study of Extended-Release Dexmethylphenidate and D,L-Methylphenidate and Placebo in a Laboratory Classroom Setting
$
30.00
Add to cart
Details
The Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Hospitalized Patients with Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Study
$
30.00
Add to cart
Details
Treatment of Children with Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Multicenter, Double-Blind, Crossover Study of Extended-Release Dexmethylphenidate and D,L-Methylphenidate and Placebo in a Laboratory Classroom Setting
$
30.00
Add to cart
Details
Page load link
Go to Top
